Catheter-associated urinary tract infections, abbreviated as CAUTIs, are the common hospital acquired infections. The infection can be associated with any part of the urinary system. If catheter-associated urinary tract infections treatment is delayed, then the infection may get severe and involve kidney infection.
The associated complications could be catheter encrustation, pyelonephritis, bladder stones, endotoxic shock and septicaemia. CAUTIs can be triggered both by bacterial and yeasts.
All the types of catheter whether made up of silicone, latex or any other polymer are prone to infections.
Catheter-associated urinary tract infections treatment market has been affected by COVID-19 pandemic in terms of delay of projects in various countries. The supply chain constraints, jammed logistics due to lockdowns and other regulatory restrictions have impacted the global catheter-associated urinary tract infections treatment market.
General shift in priority of attention from catheter-associated urinary tract infections treatment to COVID-19 has also been observed.
Catheter-Associated Urinary Tract Infections Treatment Market: Drivers and Restraints
Increasing number of hospitalization for chronic diseases is generally associated with catheterization which will be an important driver for the global catheter-associated urinary tract infections treatment market.
Growing geriatric population worldwide who have a weak immune system hence are more susceptible to urinary tract infections will increase the target customers base for the use of catheter can also be attributed to the growing global catheter-associated urinary tract infections treatment market.
Lack of sanitary amenities in the healthcare facilities in the developing countries can lead to increase in the infections resulting further driving up the global catheter-associated urinary tract infections treatment market.
Majority of people who contact infection present with fever alone which could delay the catheter-associated urinary tract infections treatment and hence hamper the growth of the global catheter-associated urinary tract infections treatment market.
To remain ‘ahead’ of your competitors, request for a sample @ https://www.futuremarketinsights.com/reports/sample/REP-GB-12575
Catheter-Associated Urinary Tract Infections Treatment Market: Overview
The global catheter-associated urinary tract infections treatment market is expected to witness a robust growth as out of all the urinary tract infections CAUTIs constitute around 80% and urinary tract infections are among the most commonly acquired infections from the hospitals.
Based on indication type Cystitis segment can be pitched to witness major growth in the global catheter-associated urinary tract infections treatment market as cystitis is the most common type of urinary tract infection.
Based on the distribution channel type the hospital pharmacies can be expected to register fastest growth in the global catheter-associated urinary tract infections treatment market because often CAUTIs will be treated in the hospital when the patient is hospitalized.
Catheter-Associated Urinary Tract Infections Treatment Market: Region-wise Outlook
North America can be estimated to be the major market in the global catheter-associated urinary tract infections treatment market for as there are reports stating that around 13 million populations in the USA is suffering from urinary incontinence per year.
Growing geriatric population in the Europe coupled with almost 20% suffering from urinary tract infection can be the reason for growth of the global catheter-associated urinary tract infections treatment market in this region.
The increasing incidence of urinary tract infections in the developing countries can be estimated to lead the growth of the global catheter-associated urinary tract infections treatment market in the South Asia East Asia and Africa.
Catheter-Associated Urinary Tract Infections Treatment Market: Key Players
The key players operating in the global catheter-associated urinary tract infections treatment market are
- GlaxoSmithKline
- Pfizer
- Cipla
- Bayer
- Johnson & Johnson
- Roche
- Novartis
- Boehringer Ingelheim
- AstraZeneca
- Shionogi
For critical insights, request for PDF Brochure @ https://www.futuremarketinsights.com/reports/brochure/rep-gb-12575
Why Future Market Insights?
- Comprehensive analysis on evolving purchase pattern across different geographies
- Detailed insights of market segments and sub-segments for historical as well as forecast period
- A competitive analysis of prominent players and emerging players in the keyword market
- Detailed information about the product innovation, mergers and acquisitions lined up in upcoming years
Ground breaking research and market player-centric solutions for the upcoming decade according to the present market scenario
About FMI:
Future Market Insights (FMI) is a leading provider of market intelligence and consulting services, serving clients in over 150 countries. FMI is headquartered in Dubai, the global financial capital, and has delivery centers in the U.S. and India. FMI’s latest market research reports and industry analysis help businesses navigate challenges and make critical decisions with confidence and clarity amidst breakneck competition. Our customized and syndicated market research reports deliver actionable insights that drive sustainable growth. A team of expert-led analysts at FMI continuously tracks emerging trends and events in a broad range of industries to ensure that our clients prepare for the evolving needs of their consumers.
Contact Us:
Mr. Debashish Roy
Unit No: AU-01-H Gold Tower (AU), Plot No: JLT-PH1-I3A,
Jumeirah Lakes Towers, Dubai,
United Arab Emirates
MARKET ACCESS DMCC Initiative
For Sales Enquiries: sales@futuremarketinsights.com
For Media Enquiries: press@futuremarketinsights.com
Website: https://www.futuremarketinsights.com